138 related articles for article (PubMed ID: 10414493)
1. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma.
Torres C; Wang H; Turner J; Shahsafaei A; Odze RD
Hum Pathol; 1999 Jul; 30(7):753-8. PubMed ID: 10414493
[TBL] [Abstract][Full Text] [Related]
2. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
[TBL] [Abstract][Full Text] [Related]
3. Preoperative chemoradiotherapy alters the expression and prognostic significance of adhesion molecules in Barrett's-associated adenocarcinoma.
Turner JR; Torres CM; Wang HH; Shahsafaei A; Richards WG; Sugarbaker D; Odze RD
Hum Pathol; 2000 Mar; 31(3):347-53. PubMed ID: 10746678
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma.
Möbius C; Stein HJ; Becker I; Feith M; Theisen J; Gais P; Jütting U; Siewert JR
World J Surg; 2004 Jul; 28(7):675-9. PubMed ID: 15175900
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor in esophageal cancer.
Kleespies A; Guba M; Jauch KW; Bruns CJ
J Surg Oncol; 2004 Aug; 87(2):95-104. PubMed ID: 15282704
[TBL] [Abstract][Full Text] [Related]
6. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
7. Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer.
McDonnell CO; Bouchier-Hayes DJ; Toomey D; Foley D; Kay EW; Leen E; Walsh TN
Br J Surg; 2003 Nov; 90(11):1373-8. PubMed ID: 14598417
[TBL] [Abstract][Full Text] [Related]
8. Pathologic prognostic factors in esophageal squamous cell carcinoma: a follow-up study of 74 patients with or without preoperative chemoradiation therapy.
Torres CM; Wang HH; Turner JR; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Mod Pathol; 1999 Oct; 12(10):961-8. PubMed ID: 10530561
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2006 Jan; 30(1):28-35. PubMed ID: 16330939
[TBL] [Abstract][Full Text] [Related]
10. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Kono T; Yazawa K; Igarashi J; Watanabe H; Nimura Y; Hanazaki K; Adachi W; Amano J
Hepatogastroenterology; 1999; 46(26):952-8. PubMed ID: 10370645
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.
Couvelard A; Paraf F; Gratio V; Scoazec JY; Hénin D; Degott C; Fléjou JF
J Pathol; 2000 Sep; 192(1):14-8. PubMed ID: 10951394
[TBL] [Abstract][Full Text] [Related]
12. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus.
Igarashi M; Dhar DK; Kubota H; Yamamoto A; El-Assal O; Nagasue N
Cancer; 1998 Apr; 82(7):1225-32. PubMed ID: 9529012
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
[TBL] [Abstract][Full Text] [Related]
15. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
[TBL] [Abstract][Full Text] [Related]
16. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
Tougeron D; Di Fiore F; Hamidou H; Rigal O; Paillot B; Michel P
Oncology; 2007; 73(5-6):328-34. PubMed ID: 18497505
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Synchronous Multiple Esophageal Cancers Composed of Squamous Cell Carcinoma and Barrett's Adenocarcinoma].
Kobayashi T; Shiozaki A; Fujiwara H; Konishi H; Arita T; Kosuga T; Morimura R; Murayama Y; Komatsu S; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Okamoto K; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1890-2. PubMed ID: 26805207
[TBL] [Abstract][Full Text] [Related]
18. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation.
Cen P; Correa AM; Lee JH; Maru D; Anandasabapathy S; Liao Z; Hofstetter WL; Swisher SG; Komaki R; Ross WA; Vaporciyan A; Ajani JA
Dis Esophagus; 2009; 22(1):32-41. PubMed ID: 19021684
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
